NOTIFICATION OF USE
for Biological and Recombinant Work
Principal Investigators are required to submit a Notification of Use (NOU) for Biological Agents, recombinant material, Human and Non-Human Primate Products for Institutional Biosafety Committee (IBC) approval prior to any work being conducted.
Addition of new agents to existing protocol is not permitted a new NOU must be submitted.
The IBC meets each first Friday of the month. All paperwork must be provided to EHS Biological and Chemical Safety (B&C) Program two weeks prior to the meeting. Contact B&C Program at (409) 772-1781 if you have any questions.
Amendment form to existing NOU:
Keck, Aerobiology and Optical Microscopy Core facilities NOU amendment form (Revised 08-12)
Recombinant Materials form (Revised 06-13)
Arthropod Section form (Revised 06-13)
Animal Section form (Revised 06-13)
Add or delete personnel on existing NOU form
Special Immunization request form (Use for FDA approved vaccines)
Co-PI Cover Page form (Revised 06-13)
Risk Assessment for Special Immunization request Form 1 and Form 2 (Use for IND/Global vaccines)